{
event: "view_event",
interaction_type: "calendar",
name: `Immunology of Diabetes Society (IDS)`,
event_type: `3rd Party Registration`,
event_category: 'Congress',
date: `Nov 5, 2024, 1:00:00 PM - Nov 5, 2024, 2:00:00 PM`,
}
Successfully Registered.
Registration Failed
Congress
Immunology of Diabetes Society (IDS)
1 hours
The symposium "A Closer Look at the Mechanisms Driving the Development of T1D" delved into the latest evidence around immunological mechanisms in T1D. We've explored the latest research findings in biomarker identification in people with T1D. Furthermore, we discussed potential benefits of combining genetic risk scoring and autoantibody screening to identify individuals at risk of developing T1D.
BR1DGE is a non-promotional global medical education program designed to advance understanding around presymptomatic type 1 diabetes and is provided by Sanofi.
This website is intended only for use by healthcare professionals in Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Denmark, Finland, France, Germany, India, Ireland, Israel, Italy, Japan, Kingdom of Saudi Arabia, Kuwait, Luxembourg, Mexico, Norway, Portugal, Qatar, Russian Federation, Spain, Sweden, The Netherlands, The United Arab Emirates, and The United Kingdom (UK).
Note: Healthcare professionals from Ireland or The UK must click the second link below to be redirected to the local website.
Are you a healthcare professional from one of the countries listed above?
You are now being redirected to a third-party website.
You are now being redirected to a third-party website.
You are about to leave the Sanofi-sponsored BR1DGE website and enter a third-party website. This link is provided as a service and does not imply endorsement by Sanofi of the information contained on the third-party website. Sanofi is not responsible for the content, views, or privacy policies of this third-party site.
